Kyle Turner Joins Life Science Connect as Chief Growth Officer

Jan 7, 2026 | News

Pittsburgh, PA – January 7, 2026

Life Science Connect (or “LSC”) is pleased to announce the appointment of Kyle Turner as its Chief Growth Officer. Mr. Turner’s addition to the team comes at a pivotal moment as the Company looks to amplify its growth capabilities to broaden the reach and impact of services it provides to readers and clients. LSC is a portfolio Company of Latticework Capital Management and Edgehill Management.

LSC, headquartered in Pittsburgh, Pennsylvania, is an intelligent, data-driven platform designed for B2B connection, collaboration, and contribution. As a leader in digital media for the life sciences, LSC is committed to enhancing professional connections within the sector to accelerate research, development, manufacturing and the application of scientific innovations.

Mr. Turner brings more than 30 years of experience in strategy, consulting, marketing and technology services to his role as Chief Growth Officer, leading go-to-market strategy and growth plans to deliver B2B solutions connecting readers and advertisers. He has held senior leadership roles in growth and sales at companies including iProspect, Merkle, and Cobalt Ventures, and has managed business development for diverse industries such as health care analytics, digital marketing, and financial services.

“I was drawn to Life Science Connect based upon the loyal reader and client base that has been developed over 40 years and am excited to join a management team and company culture that focuses on service and quality,” said Mr. Turner. “As a trusted guide and extension of our clients, LSC connects hard-to-find, high intent biopharma buyers and suppliers in the right moments of the B2B decision-making journey. We enable our client sales and marketing teams with the technical content and insights to drive revenue, long-term partnerships and innovation with our readers; a high-impact outcome bolstered by an impactful growth function.”

Mr. Turner holds a Bachelor of Arts degree in Political Science and Government from the University of Kansas and has been recognized for his achievements in business growth and client management throughout his career. His expertise combines sales leadership with strategic marketing to drive company expansion and client success.

“We’re excited about adding Kyle to our executive team. He brings a unique set of skills and experiences in leveraging data and technology to enable novel full-funnel B2B media services, and with that foundation building rapidly-scaling, highly effective commercial organizations,” said Jon Howland, CEO. “Kyle’s focus on client success and his track record in improving client outcomes will not only benefit our organization but will also substantially increase the value our client partners receive through our programs.”

LSC is actively seeking acquisition and growth opportunities to help expand their suite of capabilities for B2B sales and marketing enablement and to reach new audiences. Please contact Jon Howland (jon.howland@lifescienceleader.com) to connect further regarding a potential acquisition.

About Life Science Connect

Life Science Connect is a network of life science go-to-work solutions dedicated to a better way of connecting professionals across life science communities to advance the pace of research, development, manufacturing, and use of life science innovations. Life Science Connect facilitates mutually beneficial connections between audiences and strategic partners that accelerate the advancement of life-improving, life-extending, and life-saving therapies and devices. LSC serves a loyal, professional readership that demands original, compelling content with professional applications and facilitates engagement across the drug development lifecycle through leading digital publications, events, podcasts, and more. To learn more visit www.lifescienceconnect.com.

More News

Why PharmaSource and CDMO Live Are Joining LSC

Why PharmaSource and CDMO Live Are Joining LSC

Life Science Connect CEO Jon Howland recently joined PharmaSource Co-Founder Luke Bilton for a conversation about LSC’s acquisition of PharmaSource, CDMO Live, and External Manufacturing Leaders, and what this next chapter means for the biopharma outsourcing...

Tony Cannon Joins Life Science Connect as Chief Financial Officer

Pittsburgh, PA – May 28, 2026 Life Science Connect (or “LSC”) is pleased to announce the appointment of Tony Cannon as its Chief Financial Officer. LSC welcomes Mr. Cannon to the team at a pivotal moment as the Company continues to strengthen its financial...

Free Download

Complete the form to download our media kit.

Explore Life Science Connect’s audience data, communities, and solutions all in one place.

Select at least one.

Fields marked with * are required. Your information is secure. We will never sell your data or share it with third parties outside of Life Science Connect. By submitting this form, you acknowledge that your data will be processed in accordance with our Privacy Policy.

Your information is kept private and never sold.